Pullan's Pieces - A Business Development View of the Oncology Landscape
With an unprecedented number of new investigational agents and companies in today’s oncology space, it can be challenging to track and understand current oncology agents in clinical development, the clinical trials testing them, and what it means for the future.
In this whitepaper, biopharma partnering expert and Life Sciences consultant, Linda Pullan, PhD, explores the current oncology landscape and offers an insightful perspective on trends, pipeline by indication, dealmaking, and the top ten oncology companies and the drugs they’re developing.
In Part I of the three-part series you'll learn :
- How today’s oncology market compares to other therapeutic areas
- Unmet needs
- Who the major players are and what they are developing
- What deals are like and the stage of development they are taking place in
What we can expect in the upcoming years